The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antihelminthics Market Research Report 2024
Synopsis
Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
The global Antihelminthics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antihelminthics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihelminthics.
Report Scope
The Antihelminthics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antihelminthics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antihelminthics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Novartis
ZEISS International
Johnson & Johnson
Sanofi
Merck & Co.
GlaxoSmithKline
Astellas Pharma
Bayer
Mentis Pharma
Pfizer
Sanofi
ALLERGAN
AstraZeneca
Segment by Type
Benzimidazoles
Abamectin
Salicylanilides
Praziquantel
Other
Segment by Application
Schistosomiasis
Fasciolasis
Filariasis
Angiostrongylosis
Ascariasis
Giardiasis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antihelminthics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
The global Antihelminthics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antihelminthics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihelminthics.
Report Scope
The Antihelminthics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antihelminthics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antihelminthics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Novartis
ZEISS International
Johnson & Johnson
Sanofi
Merck & Co.
GlaxoSmithKline
Astellas Pharma
Bayer
Mentis Pharma
Pfizer
Sanofi
ALLERGAN
AstraZeneca
Segment by Type
Benzimidazoles
Abamectin
Salicylanilides
Praziquantel
Other
Segment by Application
Schistosomiasis
Fasciolasis
Filariasis
Angiostrongylosis
Ascariasis
Giardiasis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antihelminthics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antihelminthics Market Overview
1.1 Product Overview and Scope of Antihelminthics
1.2 Antihelminthics Segment by Type
1.2.1 Global Antihelminthics Market Value Comparison by Type (2024-2030)
1.2.2 Benzimidazoles
1.2.3 Abamectin
1.2.4 Salicylanilides
1.2.5 Praziquantel
1.2.6 Other
1.3 Antihelminthics Segment by Application
1.3.1 Global Antihelminthics Market Value by Application: (2024-2030)
1.3.2 Schistosomiasis
1.3.3 Fasciolasis
1.3.4 Filariasis
1.3.5 Angiostrongylosis
1.3.6 Ascariasis
1.3.7 Giardiasis
1.3.8 Other
1.4 Global Antihelminthics Market Size Estimates and Forecasts
1.4.1 Global Antihelminthics Revenue 2019-2030
1.4.2 Global Antihelminthics Sales 2019-2030
1.4.3 Global Antihelminthics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antihelminthics Market Competition by Manufacturers
2.1 Global Antihelminthics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antihelminthics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antihelminthics Average Price by Manufacturers (2019-2024)
2.4 Global Antihelminthics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antihelminthics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antihelminthics, Product Type & Application
2.7 Antihelminthics Market Competitive Situation and Trends
2.7.1 Antihelminthics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antihelminthics Players Market Share by Revenue
2.7.3 Global Antihelminthics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antihelminthics Retrospective Market Scenario by Region
3.1 Global Antihelminthics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antihelminthics Global Antihelminthics Sales by Region: 2019-2030
3.2.1 Global Antihelminthics Sales by Region: 2019-2024
3.2.2 Global Antihelminthics Sales by Region: 2025-2030
3.3 Global Antihelminthics Global Antihelminthics Revenue by Region: 2019-2030
3.3.1 Global Antihelminthics Revenue by Region: 2019-2024
3.3.2 Global Antihelminthics Revenue by Region: 2025-2030
3.4 North America Antihelminthics Market Facts & Figures by Country
3.4.1 North America Antihelminthics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antihelminthics Sales by Country (2019-2030)
3.4.3 North America Antihelminthics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antihelminthics Market Facts & Figures by Country
3.5.1 Europe Antihelminthics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antihelminthics Sales by Country (2019-2030)
3.5.3 Europe Antihelminthics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antihelminthics Market Facts & Figures by Country
3.6.1 Asia Pacific Antihelminthics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antihelminthics Sales by Country (2019-2030)
3.6.3 Asia Pacific Antihelminthics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antihelminthics Market Facts & Figures by Country
3.7.1 Latin America Antihelminthics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antihelminthics Sales by Country (2019-2030)
3.7.3 Latin America Antihelminthics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antihelminthics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antihelminthics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antihelminthics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antihelminthics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antihelminthics Sales by Type (2019-2030)
4.1.1 Global Antihelminthics Sales by Type (2019-2024)
4.1.2 Global Antihelminthics Sales by Type (2025-2030)
4.1.3 Global Antihelminthics Sales Market Share by Type (2019-2030)
4.2 Global Antihelminthics Revenue by Type (2019-2030)
4.2.1 Global Antihelminthics Revenue by Type (2019-2024)
4.2.2 Global Antihelminthics Revenue by Type (2025-2030)
4.2.3 Global Antihelminthics Revenue Market Share by Type (2019-2030)
4.3 Global Antihelminthics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antihelminthics Sales by Application (2019-2030)
5.1.1 Global Antihelminthics Sales by Application (2019-2024)
5.1.2 Global Antihelminthics Sales by Application (2025-2030)
5.1.3 Global Antihelminthics Sales Market Share by Application (2019-2030)
5.2 Global Antihelminthics Revenue by Application (2019-2030)
5.2.1 Global Antihelminthics Revenue by Application (2019-2024)
5.2.2 Global Antihelminthics Revenue by Application (2025-2030)
5.2.3 Global Antihelminthics Revenue Market Share by Application (2019-2030)
5.3 Global Antihelminthics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Antihelminthics Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Antihelminthics Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 ZEISS International
6.3.1 ZEISS International Corporation Information
6.3.2 ZEISS International Description and Business Overview
6.3.3 ZEISS International Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ZEISS International Antihelminthics Product Portfolio
6.3.5 ZEISS International Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Antihelminthics Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Antihelminthics Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Merck & Co.
6.6.1 Merck & Co. Corporation Information
6.6.2 Merck & Co. Description and Business Overview
6.6.3 Merck & Co. Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck & Co. Antihelminthics Product Portfolio
6.6.5 Merck & Co. Recent Developments/Updates
6.7 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Antihelminthics Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Astellas Pharma
6.8.1 Astellas Pharma Corporation Information
6.8.2 Astellas Pharma Description and Business Overview
6.8.3 Astellas Pharma Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Astellas Pharma Antihelminthics Product Portfolio
6.8.5 Astellas Pharma Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bayer Antihelminthics Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Mentis Pharma
6.10.1 Mentis Pharma Corporation Information
6.10.2 Mentis Pharma Description and Business Overview
6.10.3 Mentis Pharma Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Mentis Pharma Antihelminthics Product Portfolio
6.10.5 Mentis Pharma Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Antihelminthics Description and Business Overview
6.11.3 Pfizer Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Antihelminthics Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Sanofi
6.12.1 Sanofi Corporation Information
6.12.2 Sanofi Antihelminthics Description and Business Overview
6.12.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sanofi Antihelminthics Product Portfolio
6.12.5 Sanofi Recent Developments/Updates
6.13 ALLERGAN
6.13.1 ALLERGAN Corporation Information
6.13.2 ALLERGAN Antihelminthics Description and Business Overview
6.13.3 ALLERGAN Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ALLERGAN Antihelminthics Product Portfolio
6.13.5 ALLERGAN Recent Developments/Updates
6.14 AstraZeneca
6.14.1 AstraZeneca Corporation Information
6.14.2 AstraZeneca Antihelminthics Description and Business Overview
6.14.3 AstraZeneca Antihelminthics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 AstraZeneca Antihelminthics Product Portfolio
6.14.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antihelminthics Industry Chain Analysis
7.2 Antihelminthics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antihelminthics Production Mode & Process
7.4 Antihelminthics Sales and Marketing
7.4.1 Antihelminthics Sales Channels
7.4.2 Antihelminthics Distributors
7.5 Antihelminthics Customers
8 Antihelminthics Market Dynamics
8.1 Antihelminthics Industry Trends
8.2 Antihelminthics Market Drivers
8.3 Antihelminthics Market Challenges
8.4 Antihelminthics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
